Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Special Offers


Articles submitted between January 01st to 30th June, 2018 will be published as Open Access. Open Access publishing provides greater accessibility to the article. To view some of the Open access articles in the journal, please click here



Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.



30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.


Abstracted/Indexed in




New eBook

Frontiers in Clinical Drug Research – Alzheimer Disorders



You can view the contents of this eBook [here] or purchase it [here].

Endorsements

"Modern drug discovery is increasingly driven by scientific integration, the ability to pull together seemingly unrelated branches of basic and applied sciences to produce in a timely fashion innovative and efficacious solutions to multidisciplinary human health problems. The editorial staff is to be congratulated for providing a superb forum for publishing such science and the many and varied new directions that challenge how we think about and address drug discovery."

Paul A. Wender
Stanford University, USA

Forthcoming Special Issues

HERBAL DRUGS: EXPANDING HORIZONS OF CONTEMPORARY THERAPEUTICS


Guest Editor(s): Sheefali Mahant
Tentative Publication Date: February, 2018
Submit Abstract via Email Download Description
Authors' Comments
I wanted to take a few minutes to respond to your letter. Working with the Bentham Science Editorial team has been a very rewarding experience for me. I find the staff highly trained, organized and professional. This experience has made it a pleasure to publish with Bentham Sciences because the support is so helpful. Staff have been encouraging, patient and very detail oriented while helping me to fine-tune my manuscript(s) into their final format ready for public viewing. Publishing is a challenge for me due to time constraints and a full-time teaching assignment but working with the Bentham Science group has been a pleasure.

Kimberly A. Stieglitz
(STEM Biotechnology Division, Roxbury Community College, Roxbury, MA, United States)


Current Drug Discovery Technologies

,

Volume 15

-

Number 2



Biography   Open Access





Review Article





Review Article

Multifaceted Effects of Delta Opioid Receptors and DADLE in Diseases of the Nervous System

, 15(2): 94 - 108

Jea-Young Lee, M. Grant Liska, Marci Crowley, Kaya Xu, Sandra A. Acosta, Cesar V. Borlongan* and Vivian A. Guedes


DOI: 10.2174/1570163814666171010114403






Research Article

Molecular Modeling Studies of Novel Fluoroquinolone Molecules

, 15(2): 109 - 122

Tejeswara Rao Allaka, Naresh Kumar Katari*, Venkataramireddy Veeramreddy and Jaya Shree Anireddy*


DOI: 10.2174/1570163814666170829142044






Research Article

Immunomodulatory Effect of G2013 (α-L-Guluronic Acid) on the TLR2 and TLR4 in Human Mononuclear Cells

, 15(2): 123 - 131

Laleh Sharifi, Monireh Mohsenzadegan, Asghar Aghamohammadi*, Nima Rezaei, Farzaneh Tofighi Zavareh, Saied Bokaie, Mona Moshiri, Zahra Aghazadeh, Zahra Norouzbabaie, Gholamreza Azizi and Abbas Mirshafiey*


DOI: 10.2174/1570163814666170605111331






Research Article





Research Article





Research Article





A Review on Pharmacological and Clinical Aspects of Linum usitatissimum L.


Ramin Ansari, Mohammad Mehdi Zarshenas * and Amir Hossein Dadbakhsh


View Abstract View on PubMed


Effect of β-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes’ Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property


Mahsa Taeb, Abdollah Jafarzadeh, Seyed Shahabeddin Mortazavi-Jahromi, Nahid Zainodini, Mohammad Reza Mirzaei, Fahimeh Jafarnezhad-Ansariha, Zahra Aghazadeh and Abbas Mirshafiey*


View Abstract View on PubMed


Towards Breast Cancer Vaccines, Progress and Challenges


Javad Behravan*, Atefeh Razazan and Ghazal Behravan


View Abstract View on PubMed


QSAR Study of Some 1,3-Oxazolylphosphonium Derivatives as New Potent Anti-Candida Agents and Their Toxicity Evaluation


Maria M. Trush*, Vasyl Kovalishyn, Alla D. Ocheretniuk, Oleksandr L. Kobzar, Maryna V. Kachaeva, Volodymyr S. Brovarets and Larisa O. Metelytsia


View Abstract View on PubMed


Affinity Crystallography Reveals the Bioactive Compounds of Industrial Juicing Byproducts of Punica granatum for Glycogen Phosphorylase

, 2018; 15(1): 41 - 53

George A. Stravodimos, Anastassia L. Kantsadi, Anna Apostolou, Efthimios Kyriakis, Vassiliki-Nafsika Kafaski-Kanelli, Theodora Solovou, Pagona Gatzona, Panagiota G.V. Liggri, Stavroula Theofanous, Vyron A. Gorgogietas, Apostolia Kissa, Chariklia Psachoula, Angelos Lemonakis, Demetra S.M. Chatzileontiadou, Anna-Maria G. Psarra, Vassiliki T. Skamnaki, Serkos A. Haroutounian* and Demetres. D. Leonidas*


DOI: 10.2174/1570163814666170619091736



Prediction of Human Intestinal Absorption of Compounds Using Artificial Intelligence Techniques

, 2017; 14(4): 244 - 254

Rajnish Kumar*, Anju Sharma, Mohammed Haris Siddiqui and Rajesh Kumar Tiwari


DOI: 10.2174/1570163814666170404160911



QSAR Studies, Synthesis and Antibacterial Assessment of New Inhibitors Against Multidrug-Resistant Mycobacterium tuberculosis

, 2017; 14(1): 25 - 38

Vasyl Kovalishyn, Volodymyr Brovarets, Volodymyr Blagodatnyi, Iryna Kopernyk, Diana Hodyna, Svitlana Chumachenko, Oleg Shablykin, Oleksandr Kozachenko, Myhailo Vovk, Marianna Barus, Myhailo Bratenko and Larysa Metelytsia


DOI: 10.2174/1570163813666161108125227



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science | Privacy Policy